FIND, the global alliance for diagnostics

FIND, the Global Alliance for Diagnostics, is an international non-profit organization that drives innovation in the development and delivery of diagnostics to combat major diseases affecting the world's poorest populations. FIND plays a crucial role in bridging the gap between the development of new diagnostics and their implementation in health care systems, particularly in low- and middle-income countries.
Overview[edit]
FIND was established with the mission to ensure that everyone in need of diagnosis can access reliable, affordable, and appropriate testing. The organization focuses on diseases that have a significant impact on global health but are often neglected in research and development efforts, such as tuberculosis, malaria, HIV/AIDS, and neglected tropical diseases. FIND collaborates with multiple stakeholders, including governments, academia, industry, and civil society, to support the development of diagnostics from initial concept through to impact in the field.
Mission and Goals[edit]
The primary mission of FIND is to accelerate the development, evaluation, and delivery of high-quality, affordable diagnostic tests for the world's most critical diseases. This involves:
- Identifying and validating new diagnostic technologies.
- Facilitating the development and improvement of diagnostic tests.
- Enhancing access to diagnostics in low- and middle-income countries.
- Strengthening laboratory capacities and health systems.
Key Areas of Focus[edit]
FIND's work spans several disease areas and health issues, with a particular emphasis on:
- Tuberculosis: Developing and deploying new diagnostic tests to improve TB detection and management.
- Malaria: Supporting the development of rapid diagnostic tests and ensuring their effective use in endemic regions.
- HIV/AIDS: Enhancing diagnostic capacities to improve HIV detection and monitoring.
- Hepatitis C: Accelerating the development of simple, affordable diagnostic tests for hepatitis C virus (HCV) infection.
- Neglected Tropical Diseases: Working on diagnostics for diseases such as dengue, leishmaniasis, and Chagas disease.
Partnerships and Collaborations[edit]
FIND operates through a wide network of partnerships that span the public, private, and non-profit sectors. These collaborations are essential for driving innovation in diagnostics and include:
- Working with WHO and other international health bodies to align on global health priorities.
- Collaborating with diagnostic test manufacturers to develop and scale up new technologies.
- Partnering with national health ministries to implement diagnostic solutions in accordance with local needs and capacities.
Impact[edit]
FIND's efforts have led to significant advancements in the availability and use of diagnostics worldwide. By focusing on diseases that disproportionately affect the poor and marginalized, FIND contributes to global health equity and the achievement of the Sustainable Development Goals (SDGs) related to health.
Challenges and Future Directions[edit]
Despite its successes, FIND faces ongoing challenges, including the need for sustained funding, the complexity of developing diagnostics for low-resource settings, and the need to adapt to emerging health threats. Looking forward, FIND aims to continue innovating in the diagnostics space, with an emphasis on integrating digital health solutions and responding to global health emergencies.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian